304 related articles for article (PubMed ID: 22262246)
1. PAI-1 promotes the accumulation of exudate macrophages and worsens pulmonary fibrosis following type II alveolar epithelial cell injury.
Osterholzer JJ; Christensen PJ; Lama V; Horowitz JC; Hattori N; Subbotina N; Cunningham A; Lin Y; Murdock BJ; Morey RE; Olszewski MA; Lawrence DA; Simon RH; Sisson TH
J Pathol; 2012 Oct; 228(2):170-80. PubMed ID: 22262246
[TBL] [Abstract][Full Text] [Related]
2. Efferocytosis of apoptotic alveolar epithelial cells is sufficient to initiate lung fibrosis.
Kim KK; Dotson MR; Agarwal M; Yang J; Bradley PB; Subbotina N; Osterholzer JJ; Sisson TH
Cell Death Dis; 2018 Oct; 9(11):1056. PubMed ID: 30333529
[TBL] [Abstract][Full Text] [Related]
3. Implicating exudate macrophages and Ly-6C(high) monocytes in CCR2-dependent lung fibrosis following gene-targeted alveolar injury.
Osterholzer JJ; Olszewski MA; Murdock BJ; Chen GH; Erb-Downward JR; Subbotina N; Browning K; Lin Y; Morey RE; Dayrit JK; Horowitz JC; Simon RH; Sisson TH
J Immunol; 2013 Apr; 190(7):3447-57. PubMed ID: 23467934
[TBL] [Abstract][Full Text] [Related]
4. Plasminogen activator inhibitor-1 suppresses profibrotic responses in fibroblasts from fibrotic lungs.
Marudamuthu AS; Shetty SK; Bhandary YP; Karandashova S; Thompson M; Sathish V; Florova G; Hogan TB; Pabelick CM; Prakash YS; Tsukasaki Y; Fu J; Ikebe M; Idell S; Shetty S
J Biol Chem; 2015 Apr; 290(15):9428-41. PubMed ID: 25648892
[TBL] [Abstract][Full Text] [Related]
5. Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis.
Senoo T; Hattori N; Tanimoto T; Furonaka M; Ishikawa N; Fujitaka K; Haruta Y; Murai H; Yokoyama A; Kohno N
Thorax; 2010 Apr; 65(4):334-40. PubMed ID: 20388759
[TBL] [Abstract][Full Text] [Related]
6. The vitronectin-binding function of PAI-1 exacerbates lung fibrosis in mice.
Courey AJ; Horowitz JC; Kim KK; Koh TJ; Novak ML; Subbotina N; Warnock M; Xue B; Cunningham AK; Lin Y; Goldklang MP; Simon RH; Lawrence DA; Sisson TH
Blood; 2011 Aug; 118(8):2313-21. PubMed ID: 21734232
[TBL] [Abstract][Full Text] [Related]
7. Regulation of alveolar epithelial cell apoptosis and pulmonary fibrosis by coordinate expression of components of the fibrinolytic system.
Bhandary YP; Shetty SK; Marudamuthu AS; Gyetko MR; Idell S; Gharaee-Kermani M; Shetty RS; Starcher BC; Shetty S
Am J Physiol Lung Cell Mol Physiol; 2012 Mar; 302(5):L463-73. PubMed ID: 22140072
[TBL] [Abstract][Full Text] [Related]
8. Regulation of p53-mediated changes in the uPA-fibrinolytic system and in lung injury by loss of surfactant protein C expression in alveolar epithelial cells.
Puthusseri B; Marudamuthu A; Tiwari N; Fu J; Idell S; Shetty S
Am J Physiol Lung Cell Mol Physiol; 2017 Jun; 312(6):L783-L796. PubMed ID: 28385810
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor 2 decreases bleomycin-induced pulmonary fibrosis and inhibits fibroblast collagen production and myofibroblast differentiation.
Koo HY; El-Baz LM; House S; Cilvik SN; Dorry SJ; Shoukry NM; Salem ML; Hafez HS; Dulin NO; Ornitz DM; Guzy RD
J Pathol; 2018 Sep; 246(1):54-66. PubMed ID: 29873400
[TBL] [Abstract][Full Text] [Related]
10. A murine model of acute lung injury identifies growth factors to promote tissue repair and their biomarkers.
Kurosawa T; Miyoshi S; Yamazaki S; Nishina T; Mikami T; Oikawa A; Homma S; Nakano H
Genes Cells; 2019 Feb; 24(2):112-125. PubMed ID: 30474194
[TBL] [Abstract][Full Text] [Related]
11. Regulation of lung injury and fibrosis by p53-mediated changes in urokinase and plasminogen activator inhibitor-1.
Bhandary YP; Shetty SK; Marudamuthu AS; Ji HL; Neuenschwander PF; Boggaram V; Morris GF; Fu J; Idell S; Shetty S
Am J Pathol; 2013 Jul; 183(1):131-43. PubMed ID: 23665346
[TBL] [Abstract][Full Text] [Related]
12. YY1 mediates TGF-β1-induced EMT and pro-fibrogenesis in alveolar epithelial cells.
Zhang C; Zhu X; Hua Y; Zhao Q; Wang K; Zhen L; Wang G; Lü J; Luo A; Cho WC; Lin X; Yu Z
Respir Res; 2019 Nov; 20(1):249. PubMed ID: 31703732
[TBL] [Abstract][Full Text] [Related]
13. Role of the urokinase-fibrinolytic system in epithelial-mesenchymal transition during lung injury.
Marudamuthu AS; Bhandary YP; Shetty SK; Fu J; Sathish V; Prakash Y; Shetty S
Am J Pathol; 2015 Jan; 185(1):55-68. PubMed ID: 25447049
[TBL] [Abstract][Full Text] [Related]
14. Myeloid cell dynamics in bleomycin-induced pulmonary injury in mice; effects of anti-TNFα antibody.
Venosa A; Gow JG; Taylor S; Golden TN; Murray A; Abramova E; Malaviya R; Laskin DL; Gow AJ
Toxicol Appl Pharmacol; 2021 Apr; 417():115470. PubMed ID: 33647319
[TBL] [Abstract][Full Text] [Related]
15. A pneumocyte-macrophage paracrine lipid axis drives the lung toward fibrosis.
Romero F; Shah D; Duong M; Penn RB; Fessler MB; Madenspacher J; Stafstrom W; Kavuru M; Lu B; Kallen CB; Walsh K; Summer R
Am J Respir Cell Mol Biol; 2015 Jul; 53(1):74-86. PubMed ID: 25409201
[TBL] [Abstract][Full Text] [Related]
16. Deficiency of CARMA3 attenuates the development of bleomycin induced pulmonary fibrosis.
Wu Y; Qi Y; Qiu Z; Chen W
Biochem Biophys Res Commun; 2021 Dec; 581():81-88. PubMed ID: 34656852
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen activator inhibitor-1 impairs alveolar epithelial repair by binding to vitronectin.
Lazar MH; Christensen PJ; Du M; Yu B; Subbotina NM; Hanson KE; Hansen JM; White ES; Simon RH; Sisson TH
Am J Respir Cell Mol Biol; 2004 Dec; 31(6):672-8. PubMed ID: 15308506
[TBL] [Abstract][Full Text] [Related]
18. Ligand-independent transforming growth factor-β type I receptor signalling mediates type I collagen-induced epithelial-mesenchymal transition.
DeMaio L; Buckley ST; Krishnaveni MS; Flodby P; Dubourd M; Banfalvi A; Xing Y; Ehrhardt C; Minoo P; Zhou B; Crandall ED; Borok Z
J Pathol; 2012 Mar; 226(4):633-44. PubMed ID: 21984393
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a flexible AAV-DTR/DT mouse model of acute epithelial lung injury.
Griesser E; Schönberger T; Stierstorfer B; Wyatt H; Rist W; Lamla T; Thomas MJ; Lamb D; Geillinger-Kästle K
Am J Physiol Lung Cell Mol Physiol; 2022 Aug; 323(2):L206-L218. PubMed ID: 35762632
[TBL] [Abstract][Full Text] [Related]
20. The plasminogen activation system reduces fibrosis in the lung by a hepatocyte growth factor-dependent mechanism.
Hattori N; Mizuno S; Yoshida Y; Chin K; Mishima M; Sisson TH; Simon RH; Nakamura T; Miyake M
Am J Pathol; 2004 Mar; 164(3):1091-8. PubMed ID: 14982862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
